Student interns presented their research to the NCI at Frederick community during the annual Student Poster Days event, held in the Building 549 lobby and the Advanced Technology Research Facility (ATRF) atrium over two days.
While it was the pleasant weather, live music, and scores of vendors that drew thousands to Frederick’s 2017 In The Street festival, it was the eye-catching activities and prizes that drew attendees to the Frederick National Laboratory for Cancer Research tent.
A team of scientists and specialists from NCI at Frederick, NCI at Bethesda, the Frederick National Laboratory for Cancer Research, and Data Management Services, Inc., has developed the first method for identifying natural products that could increase the effectiveness of camptothecin-based cancer treatments.
The National Cancer Institute and Children’s Oncology Group recently opened enrollment for a new Phase II trial of personalized precision cancer therapies. Called the Pediatric Molecular Analysis for Therapy Choice (Pediatric MATCH), the trial seeks to treat children and adolescents aged 1–21 whose solid tumors have failed to respond to or re-emerged after traditional cancer treatments.